A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Arcellx, Inc.
Arcellx, Inc.
Brain Inflammation Collaborative
Tongji Hospital
Tianjin Huanhu Hospital
The First People's Hospital of Changzhou
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
University of Bern
University Hospital, Toulouse
Tongji Hospital
Tongji Hospital
Assiut University
Xuanwu Hospital, Beijing